Borosil Scientific Limited delivered exceptional financial results for the quarter ended March 2026, with consolidated net profit surging 213.84% to ₹27.21 crores compared to ₹8.67 crores in the corresponding quarter of the previous year. According to the latest financial statements, revenue from operations increased 10.57% to ₹143.17 crores from ₹129.48 crores in Q4 FY25. The company's operating profit margin (OPM) improved significantly to 22.43% from 12.80% in the previous year, demonstrating enhanced operational efficiency. For the full year FY26, net profit rose 29.14% to ₹34.61 crores from ₹26.80 crores in FY25, while total revenue grew 6.58% to ₹467.34 crores from ₹438.49 crores.
The board of Borosil Scientific has approved a significant fund raising initiative at its meeting held on May 20, 2026. According to reports from Business Standard, the board has decided to seek shareholder approval through an enabling resolution at the upcoming Annual General Meeting. This approval authorizes the board to raise funds as and when required, subject to regulatory compliance. The board's decision comes as the company continues to strengthen its financial position following the strong Q4 FY26 performance.
The approved resolution grants the board authority to raise funds up to ₹250 crore using various financial instruments. As reported by Business Standard, the fund raising can be executed through qualified institutional placement, further public officer, FCCBs, or any other method permitted under applicable laws. The board retains flexibility to choose the most appropriate funding mechanism based on market conditions and regulatory requirements. The company's strong financial performance provides a solid foundation for this capital raising initiative.
In significant management developments, the board approved the re-appointment of Mr. Vinayak Madhukar Patankar as Whole-time Director & CEO for a period of 3 years effective from December 2, 2026, subject to shareholder approval. Additionally, Mr. Sanjay Gupta resigned as Company Secretary and Compliance Officer effective May 20, 2026, and was succeeded by Mr. Ramavtar Sharma as the new Company Secretary & Compliance Officer effective May 21, 2026. The board also approved the re-appointment of M/s. Chaturvedi & Shah LLP as Statutory Auditors for a second term of five consecutive years, subject to shareholder approval. Furthermore, Mr. Bhaunik Shah was appointed as Company Secretary and Compliance Officer, transitioning from his interim role effective May 19, 2026.
The fund raising initiative is subject to specific regulatory approvals and statutory requirements. According to Business Standard, the board's authority is contingent upon obtaining necessary regulatory and statutory approvals as may be required under applicable laws. The company's audited financial results were approved by the board and received an unmodified opinion from statutory auditor M/s. Chaturvedi & Shah LLP for the year ended March 31, 2026. The board also approved modifications to the "Borosil Limited – Employee Stock Option Scheme 2020" to align with current business requirements.
